Evidence map›Paper›PMID 39660492›Full record

Observational studyCurrent cardiology reviews2025

Atrial Fibrillation Ablation in Heart Failure and Preserved Ejection Fraction: An Observational Study of Risk Factors for Heart Failure Hospitalization.

Rundi Qi, Hailei Liu, Yue Zhu, Nan Wu, Kexin Wang, Xiangwei Ding, Zhoushan Gu, Mingfang Li, Hongwu Chen, Weizhu Ju and 2 more

Abstract readObservational StudyMulticenter Study
PubMed Full text at PMC Publisher
In one paragraph

Observational study in Current cardiology reviews, 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 1 paper.

0numbers the graph read from it
0cells of the map it votes in
1citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

1 citing paper in PubMed.

  1. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

12 authors.

Rundi QiDepartment of Cardiology, The First Affiliated Hospital of Nanjing Medical University, Nanjing, China.
Hailei LiuDepartment of Cardiology, The First Affiliated Hospital of Nanjing Medical University, Nanjing, China.
Yue ZhuDepartment of Cardiology, The First Affiliated Hospital of Nanjing Medical University, Nanjing, China.
Nan WuDepartment of Cardiology, The First Affiliated Hospital of Nanjing Medical University, Nanjing, China.
Kexin WangDepartment of Cardiology, The First Affiliated Hospital of Nanjing Medical University, Nanjing, China.
Xiangwei DingDepartment of Cardiology, Taizhou School of Clinical Medicine, The Affiliated Taizhou People's Hospital of Nanjing Medical University, Nanjing Medical University, Taizhou, China.
Zhoushan GuDepartment of Cardiology, Affiliated Hospital of Nantong University, Nantong, China.
Mingfang LiDepartment of Cardiology, The First Affiliated Hospital of Nanjing Medical University, Nanjing, China.
Hongwu ChenDepartment of Cardiology, The First Affiliated Hospital of Nanjing Medical University, Nanjing, China.
Weizhu JuDepartment of Cardiology, The First Affiliated Hospital of Nanjing Medical University, Nanjing, China.
Xin LiDepartment of Cardiology, Nanjing BenQ Medical Center, The Affiliated BenQ Hospital of Nanjing Medical University, Nanjing, China.
Minglong ChenDepartment of Cardiology, The First Affiliated Hospital of Nanjing Medical University, Nanjing, China.

Funding

Jiangsu Commission of Health LKM2023029Nanjing Medical University Science and Technology Development Fund NMUB20210181
6 · The paper itself

Abstract

introductionLong-term heart failure hospitalization (HFH) after radiofrequency catheter ablation (RFCA) in atrial fibrillation (AF) patients with heart failure and preserved ejection fraction (HFpEF) and its risk factors remain to be investigated.

methodsAF patients with HFpEF who underwent RFCA from January, 2014 to December, 2018 from three centers were retrospectively included. Patients were assigned to the training and testing cohorts, respectively. In the training cohort, logistic regression analyses were performed to discriminate those with and without HFH. A scoring system was developed accordingly and validated.

resultsA total of 417 AF patients with HFpEF receiving RFCA were enrolled. About 35 patients (8.4%) had HFH for 6 years. In the training cohort, the use of diuretics, atrial tachycardia (AT)/AF recurrence, prior HFH, and female sex were independent predictors of HFH in the multivariable analysis. A DAPF score (ranging from 0 to 9.0) was developed. The area under the receiver operating characteristic curve (AUC) of the DAPF score was 0.880 (95% CI, 0.830- 0.929). A DAPF score ≥3.5 could predict HFH with a sensitivity of 81.8% and a specificity of 74.6%. The performance in the testing cohort remained robust (AUC, 0.858; 95% CI, 0.749- 0.967).

conclusionHFH in patients with AF and HFpEF after RFCA is not rare. The DAPF score could predict the risk of HFH in AF patients with HFpEF after RFCA and guide our treatment strategy.

Indexed as

Atrial FibrillationCatheter AblationHeart FailureHospitalizationStroke VolumeAgedFemaleHumansMaleMiddle AgedRetrospective StudiesRisk Factorsantiarrhythmic drugsAtrial fibrillationcardiovascular outcomes.heart failureheart failure hospitalizationpreserved ejection fractionradiofrequency catheter ablation

Identifiers

PMID39660492
PMCPMC12172218

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.